Genetic Studies in Familial Non-medullary Thyroid Cancer

Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer

Recruiting Observational Study
Non-Medullary Thyroid Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
7 – 90
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Who this trial is looking for

This trial is looking for individuals with a family history of non-medullary thyroid cancer. Participants will undergo evaluations and may provide biological samples while being monitored for the disease.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am at least 7 years old
  • I have two close family members with non-medullary thyroid cancer
  • I have been diagnosed with non-medullary thyroid cancer and one family member with it
  • I am part of a family with two or more close relatives with documented non-medullary thyroid cancer
  • I understand the informed consent document
  • I can complete a family history questionnaire

You may not be able to join if

  • I am unwilling or unable to give informed consent

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Background: \- Researchers are studying types of thyroid cancer that seem to cluster in families. Non-medullary thyroid cancer accounts for the vast majority of all types of thyroid cancer, but little is known about possible genes that may cause the cancer. More research is needed to develop the best ways to screen for familial non-medullary thyroid cancer (FNMTC) so that it can be diagnosed and …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: Subjects will be selected for this protocol based on either a clinical diagnosis of non-medullary thyroid cancer and the presence of one family member with the disease or the presence of 2 living family members with this disease. Patient selection for this protocol will not be…
Contacts

Padmasree Veeraraghavan, R.N.

(301) 451-7710

ncieobinquiry@mail.nih.gov

CONTACT

Joanna Klubo-Gwiezdzinska, M.D.

(301) 496-5052

joanna.klubo-gwiezdzinska@nih.gov

CONTACT